Abatacept reduces the rate of progression to RA and improves the rate of remission in patients with palindromic rheumatism ...

The American College of Rheumatology has updated its systemic lupus erythematosus treatment guidelines for the first time ...

Hydroxychloroquine for COVID-19: President Trump's promotion of the malaria drug has led to a surge in demand. But a New York woman died after being prescribed the drug cocktail.

Hydroxychloroquine is tied to reduced preeclampsia risk but not preterm birth risk in pregnant patients with lupus in a ...

Over 200,000 people worldwide could receive the old antimalarial drugs chloroquine and hydroxychloroquine across more than 130 clinical trials designed to treat or prevent COVID-19, according to ...

Hydroxychloroquine, the anti-malarial drug touted and previously taken by President Donald Trump to fight coronavirus, has fallen out of favor and public view as studies — like one halted Friday ...

Hydroxychloroquine is ineffective and unsafe in the treatment of COVID-19: This is the belief held by millions of Americans and many healthcare professionals. After months of randomized clinical tr… ...

Find patient medical information for Hydroxychloroquine on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings ...

President Trump said he would take hydroxychloroquine again “if he thought he was exposed” to the novel coronavirus, even after extensive testing has proven that the anti-malaria drug isn’t ...

Hydroxychloroquine is taken by mouth as a pill or tablet that you take once or twice a day. The typical dose for adults with lupus is between 200 mg and 400 mg per day. Your dose is based on your ...

In 1946, hydroxychloroquine was synthesized, and in 1955, it was proposed as a safer alternative to its chemical predecessor. Initial studies on hydroxychloroquine and COVID-19.

Hydroxychloroquine and azithromycin have been used to treat patients with coronavirus disease 2019 (Covid-19). However, evidence on the safety and efficacy of these therapies is limited.We conducte ...